CANDEL THERAPEUTICS, INC. (CADL)

SEC filing

CANDEL THERAPEUTICS, INC.

CADL · CIK 1841387

4 · Sep 11, 2026 · Director, Chief Executive Officer Tak Paul Peter sold 280.25K shares at $11.28/share ($3.2M); exercised options for 250K shares

Director, Chief Executive Officer Tak Paul Peter sold 280.25K shares at $11.28/share ($3.2M); exercised options for 250K shares

xslF345X06/ownership.xml

xslF345X06/ownership.xmlSEC.gov

Graphics and non-inline formats (not embedded below).